These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 26823832)

  • 21. Endogenous microRNA-424 predicts clinical outcome and its inhibition acts as cancer suppressor in human non-small cell lung cancer.
    Wang Y; Lv Z; Fu J; Wang Z; Fan Z; Lei T
    Biomed Pharmacother; 2017 May; 89():208-214. PubMed ID: 28231541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression.
    Qu CH; Sun QY; Zhang FM; Jia YM
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer.
    Tang R; Liang L; Luo D; Feng Z; Huang Q; He R; Gan T; Yang L; Chen G
    Med Sci Monit; 2015 Aug; 21():2514-20. PubMed ID: 26305739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
    Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
    Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.
    Zhang J; Wang T; Zhang Y; Wang H; Wu Y; Liu K; Pei C
    Cancer Biomark; 2018; 21(4):763-768. PubMed ID: 29286916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-148b is a potential prognostic biomarker and predictor of response to radiotherapy in non-small-cell lung cancer.
    Wang R; Ye F; Zhen Q; Song T; Tan G; Chu W; Zhang Y; Lv B; Zhao X; Liu J
    J Physiol Biochem; 2016 Jun; 72(2):337-43. PubMed ID: 27083571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of microRNA-301a in nonsmall-cell lung cancer and its clinical significance.
    Shi YK; Zang QL; Li GX; Huang Y; Wang SZ
    J Cancer Res Ther; 2016; 12(2):693-8. PubMed ID: 27461635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-1298 is downregulated in non-small cell lung cancer and suppresses tumor progression in tumor cells.
    Du Z; Wu J; Wang J; Liang Y; Zhang S; Shang Z; Zuo W
    Diagn Pathol; 2019 Dec; 14(1):132. PubMed ID: 31801557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High circulating miR-18a, miR-20a, and miR-92a expression correlates with poor prognosis in patients with non-small cell lung cancer.
    Xu X; Zhu S; Tao Z; Ye S
    Cancer Med; 2018 Jan; 7(1):21-31. PubMed ID: 29266846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN.
    Zhu DY; Li XN; Qi Y; Liu DL; Yang Y; Zhao J; Zhang CY; Wu K; Zhao S
    Biomed Pharmacother; 2016 Jul; 81():79-85. PubMed ID: 27261580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of miR-361-5p associates with aggressive clinicopathological features and unfavorable prognosis in non-small cell lung cancer.
    Zhuang ZL; Tian FM; Sun CL
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5132-5136. PubMed ID: 28051257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
    Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
    Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
    Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of miR-133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder.
    Chen X; Wu B; Xu Z; Li S; Tan S; Liu X; Wang K
    Cancer Med; 2016 Aug; 5(8):1856-62. PubMed ID: 27292588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.
    Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
    Int J Clin Exp Pathol; 2014; 7(12):8881-6. PubMed ID: 25674259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
    Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
    BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.
    Zhu J; Zhang Y; Yang X; Jin L
    Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.